NeoGenomics, Inc. Amortization of Debt Discount (Premium)
NeoGenomics, Inc. (NEO) reported Amortization of Debt Discount (Premium) of $753.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-07-28
- NeoGenomics, Inc. amortization of debt discount (premium) for the quarter ending 2025-12-31 was $374.00K, a 45.32% decline year-over-year.
- NeoGenomics, Inc. amortization of debt discount (premium) for the quarter ending 2025-09-30 was $372.00K, a 45.53% decline year-over-year.
- NeoGenomics, Inc. amortization of debt discount (premium) for the quarter ending 2025-06-30 was $477.00K, a 29.85% decline year-over-year.
- NeoGenomics, Inc. amortization of debt discount (premium) for the quarter ending 2025-03-31 was $687.00K, a 1.33% increase year-over-year.
- NeoGenomics, Inc. amortization of debt discount (premium) for fiscal 2025 was $1.91M, a 29.91% decline from fiscal 2024.
- NeoGenomics, Inc. amortization of debt discount (premium) for fiscal 2024 was $2.73M, a 1.26% increase from fiscal 2023.
- NeoGenomics, Inc. amortization of debt discount (premium) for fiscal 2023 was $2.69M, a 1.28% increase from fiscal 2022.
- NeoGenomics, Inc. amortization of debt discount (premium) for fiscal 2022 was $2.66M, a 3.67% increase from fiscal 2021.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $753.00K 10-Q · filed 2026-07-28 | |||
| 2025-12-31 | $374.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $746.00K derived: sum of 2 quarters · filed 2026-02-17 | $1.22M derived: sum of 3 quarters · filed 2026-07-28 | $1.91M 10-K · filed 2026-02-17 |
| 2025-09-30 | $372.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $849.00K derived: sum of 2 quarters · filed 2026-07-28 | $1.54M 10-Q · filed 2025-10-28 | $2.22M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | $477.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $1.16M 10-Q · filed 2026-07-28 | $1.85M derived: sum of 3 quarters · filed 2026-07-28 | $2.53M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $687.00K 10-Q · filed 2025-04-29 | $1.37M derived: sum of 2 quarters · filed 2026-02-17 | $2.05M derived: sum of 3 quarters · filed 2026-02-17 | $2.73M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | $684.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.37M derived: sum of 2 quarters · filed 2026-02-17 | $2.05M derived: sum of 3 quarters · filed 2026-02-17 | $2.73M 10-K · filed 2026-02-17 |
| 2024-09-30 | $683.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.36M derived: sum of 2 quarters · filed 2025-10-28 | $2.04M 10-Q · filed 2025-10-28 | $2.72M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $680.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $1.36M 10-Q · filed 2025-07-29 | $2.03M derived: sum of 3 quarters · filed 2026-02-17 | $2.71M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $678.00K 10-Q · filed 2025-04-29 | $1.35M derived: sum of 2 quarters · filed 2026-02-17 | $2.03M derived: sum of 3 quarters · filed 2026-02-17 | $2.70M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $676.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.35M derived: sum of 2 quarters · filed 2026-02-17 | $2.02M derived: sum of 3 quarters · filed 2026-02-17 | $2.69M 10-K · filed 2026-02-17 |
| 2023-09-30 | $674.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $1.35M derived: sum of 2 quarters · filed 2024-11-05 | $2.02M 10-Q · filed 2024-11-05 | $2.68M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $672.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $1.34M 10-Q · filed 2024-07-30 | $2.01M derived: sum of 3 quarters · filed 2025-02-18 | $2.67M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $669.00K 10-Q · filed 2024-04-30 | $1.34M derived: sum of 2 quarters · filed 2025-02-18 | $2.00M derived: sum of 3 quarters · filed 2025-02-18 | $2.67M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $668.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $1.33M derived: sum of 2 quarters · filed 2025-02-18 | $2.00M derived: sum of 3 quarters · filed 2025-02-18 | $2.66M 10-K · filed 2025-02-18 |
| 2022-09-30 | $665.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $1.33M derived: sum of 2 quarters · filed 2023-11-06 | $1.99M 10-Q · filed 2023-11-06 | $2.65M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $663.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.32M 10-Q · filed 2023-08-08 | $1.98M derived: sum of 3 quarters · filed 2024-02-20 | $2.64M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $661.00K 10-Q · filed 2023-05-09 | $1.32M derived: sum of 2 quarters · filed 2024-02-20 | $1.98M derived: sum of 3 quarters · filed 2024-02-20 | $2.63M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $659.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $1.32M derived: sum of 2 quarters · filed 2024-02-20 | $1.97M derived: sum of 3 quarters · filed 2024-02-20 | $2.56M 10-K · filed 2024-02-20 |
| 2021-09-30 | $657.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.31M derived: sum of 2 quarters · filed 2022-11-08 | $1.90M 10-Q · filed 2022-11-08 | $3.56M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $654.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.25M 10-Q · filed 2022-08-09 | $2.90M derived: sum of 3 quarters · filed 2023-02-24 | $4.74M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $593.00K 10-Q · filed 2022-05-09 | $2.25M derived: sum of 2 quarters · filed 2023-02-24 | $4.09M derived: sum of 3 quarters · filed 2023-02-24 | $4.95M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $3.49M derived: sum of 2 quarters · filed 2023-02-24 | $4.36M derived: sum of 3 quarters · filed 2023-02-24 | $4.36M 10-K · filed 2023-02-24 |
| 2020-09-30 | $1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.71M derived: sum of 2 quarters · filed 2021-11-04 | $2.71M 10-Q · filed 2021-11-04 | $2.71M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $864.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $864.00K 10-Q · filed 2021-08-09 | $864.00K derived: sum of 3 quarters · filed 2022-02-25 | $864.00K derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $0.00 derived: sum of 3 quarters · filed 2022-02-25 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $0.00 10-K · filed 2022-02-25 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-07-31 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |